Revenue Growth
Enerpac's revenue increased 5.1% on a reported basis and 5% on an organic basis in Q2 2025, indicating strong performance despite a soft industrial sector.
Cortland Biomedical Growth
Cortland Biomedical posted a growth of 33%, driven by improved comparisons with a year-ago period impacted by shipment delays.
Geographic Expansion
High single-digit growth in the Americas and APAC regions, with the ECX program contributing to share gains.
Earnings Per Share Increase
Adjusted earnings per share were $0.39, an 8% increase from the previous year.
Strong Balance Sheet
Net debt was $73 million with a net debt to adjusted EBITDA ratio of 0.5, and total liquidity of $518 million.
Successful Product Launches
Positive reception of new products launched under the revamped innovation program, with further expansions expected in 2025 and 2026.
E-commerce Growth
E-commerce revenue increased by 43% year-over-year in Q2 and 36% in the first half of fiscal 2025.